Pharmaceutical Technology on MSN
Cytokinetics receives FDA approval for MYQORZO tablets for oHCM
Cytokinetics has announced that the FDA has approved MYQORZO tablets in 5mg, 10mg, 15mg, and 20mg doses for adults with oHCM .
Ventricular resection is a type of open-heart surgery to reshape and resize the heart. The surgery may help to improve survival in people with heart failure. Ventricular resection is a surgical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback